Skip to content

Clinical trial to evaluate the efficacy of electrical stimulation of the brain with direct electrical current on depression after stroke

Clinical trial to evaluate the efficacy of electrical stimulation of the brain with direct electrical current on depression after stroke

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017030921965N4
Enrollment
150
Registered
2017-05-28
Start date
2017-03-09
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive episode. Depressive episode

Interventions

Intervention 1: Intervention group1: The treatment will be carried out in 15 sessions, three sessions per week and a consistent, direct and uniform current will be sent to the brain through anodal ty
Treatment - Other
Intervention group1: The treatment will be carried out in 15 sessions, three sessions per week and a consistent, direct and uniform current will be sent to the brain through anodal type waves for up
Control group: The control group will get electrical stimulation (TDCS) in the initial moments of each treatment session then the current will be switched off.
Intervention group2: The treatment will be carried out in 15 sessions, three sessions per week and a consistent, direct and uniform current will be sent to the brain through cathodal type waves for

Sponsors

Investigator
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with the brain stroke, people aged at least 21 years during 48 hours of their first brain stroke; Exclusion criteria: cardiac pacemaker or metal implants or instruments inside the patient’s body, treatment resistant seizures, using any psychoactive or stimulation drugs, pregnancy, the existence of any neurological condition affecting sensory-motor systems, such as brain tumors, dementia, or severe substance abuse and medications and Severe cognitive declines.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Treatment effectiveness will be assessed on 15 days, 1 month and 3 month later. Method of measurement: Beck Depression questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Homa Zarrabi

Guilan University Of Medical Sciences

dr_zarrabi2000@ yahoo.com+98 13 3366 6268

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026